Cardiol Therapeutics Inc.
General ticker "CRDL" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $141.7M (TTM average)
Cardiol Therapeutics Inc. follows the US Stock Market performance with the rate: 37.4%.
Estimated limits based on current volatility of 4.1%: low 0.88$, high 0.96$
Factors to consider:
- Total employees count: 18 (+5.9%) as of 2024
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.53$, 1.43$]
- 2026-12-31 to 2027-12-31 estimated range: [0.45$, 1.26$]
Financial Metrics affecting the CRDL estimates:
- Positive: with PPE of -3.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Positive: -0.07 < Investing cash flow per share per price, % of -0.02
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
- Negative: 68.95 < Shareholder equity ratio, % of 75.69 <= 81.82
- Negative: negative Industry operating income (median)
Short-term CRDL quotes
Long-term CRDL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$22.47MM | CA$40.28MM | CA$34.32MM |
| Operating Income | CA$-22.47MM | CA$-40.28MM | CA$-34.32MM |
| Non-Operating Income | CA$1.25MM | CA$3.60MM | CA$0.50MM |
| R&D Expense | CA$10.73MM | CA$14.01MM | CA$14.02MM |
| Income(Loss) | CA$-21.22MM | CA$-36.68MM | CA$-33.82MM |
| Net Income(Loss)* | CA$-28.13MM | CA$-36.68MM | CA$-33.82MM |
| Stockholders Equity | CA$28.25MM | CA$24.73MM | CA$17.88MM |
| Assets | CA$36.70MM | CA$31.86MM | CA$23.62MM |
| Operating Cash Flow | CA$-25.18MM | CA$-25.06MM | CA$-23.85MM |
| Capital expenditure | CA$0.06MM | CA$0.02MM | CA$0.02MM |
| Investing Cash Flow | CA$-0.06MM | CA$-0.02MM | CA$-0.02MM |
| Financing Cash Flow | CA$-0.06MM | CA$18.84MM | CA$15.54MM |
| Earnings Per Share** | CA$-0.44 | CA$-0.51 | CA$-0.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.